Treatment with a novel hexavalent OX40 agonist remodels the tumor microenvironment to favor anti-tumor immunity in mice

Authors

M Kasiewicz
Will Redmond, ProvidenceFollow
See full list of authors in comments

Document Type

Abstract

Publication Date

11-1-2023

Keywords

oregon; chiles

Clinical Institute

Cancer

Specialty/Research Institute

Oncology

Comments

Kasiewicz M, Rolig A, Yadav R, Durana YDD, Redmond WL. SITC Annual Meeting; November 1-5; San Diego, CA. 2023;11(Suppl 1): 1360.